0.68 - 0.75
0.33 - 0.86
12.91M / 4.66M (Avg.)
35.00 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
30.01%
Revenue growth under 50% of 0819.HK's 100.00%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-29.38%
Negative gross profit growth while 0819.HK is at 100.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
1377.55%
EBIT growth of 1377.55% while 0819.HK is zero. Bruce Berkowitz would see if small gains can be scaled further.
1247.29%
Operating income growth above 1.5x 0819.HK's 100.00%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
342.74%
Net income growth above 1.5x 0819.HK's 100.00%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
175.79%
EPS growth above 1.5x 0819.HK's 100.00%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
175.79%
Diluted EPS growth above 1.5x 0819.HK's 100.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
85.89%
Share change of 85.89% while 0819.HK is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
85.89%
Diluted share change of 85.89% while 0819.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-48.08%
Negative OCF growth while 0819.HK is at 100.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-703.40%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
9.22%
10Y CAGR of 9.22% while 0819.HK is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
106.83%
5Y CAGR of 106.83% while 0819.HK is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
276.76%
3Y CAGR of 276.76% while 0819.HK is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
59.64%
OCF/share CAGR of 59.64% while 0819.HK is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
-120.26%
Negative 5Y OCF/share CAGR while 0819.HK is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
39.22%
3Y OCF/share CAGR of 39.22% while 0819.HK is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
177.06%
10Y net income/share CAGR of 177.06% while 0819.HK is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
165.70%
Net income/share CAGR of 165.70% while 0819.HK is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
437.69%
3Y net income/share CAGR of 437.69% while 0819.HK is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-241.39%
We cut SG&A while 0819.HK invests at 100.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.